Key result
Published studies on population aging disease burden show methodological limits requiring robust systematic evaluation.
Why the study?
Existing decomposition studies used varied methods and evaluated population ageing in limited countries and diseases, highlighting the need for a systematic evaluation with a robust decomposition method across countries and diseases.
Key points are not available for this paper at this time.
Design
Review
Prior studies limited by inconsistent methods and narrow scope; leaves open robust global quantification of aging's contribution to disease burden.
The published decomposition studies adopted various methods and only evaluated the impact of population ageing in very limited countries and for several diseases. Therefore, a systematic evaluation using robust decomposition method is very necessary to evaluate the impact of population aging on disease burden across countries and diseases.
No takes yet. Share an insight, caveat, or question.
A 2020 study studied this question. Published decomposition studies on the disease burden of population aging are limited in scope and methodology, necessitating robust systematic evaluations across countries and diseases.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: